Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health News of Alabama.
SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 Program Update
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer...
Santa Salutes brings cheer year-round to Veterans
The halls of the West Palm Beach VA Healthcare System (WPBVAHCS) Community Living Center (CLC) filled with cheer as Santa Claus made his rounds, not just for the holiday, but as part of a new year-round initiative designed to brighten the days of...
Owner: American Government
MADISON VETERANS SERVICE OFFICER I
AN EQUAL OPPORTUNITY EMPLOYER INFORMATION SHEET FOR VETERANS SEEKING EMPLOYMENT AS AN EXECUTIVE ADMINISTRATOR WITH THE STATE OF ALABAMA DEPARTMENT OF VETERANS AFFAIRS Basic Eligibility Requirements: Veteran Service Officers I must be residents and...
Owner: American Government
MedCerts Partners with eHBCU to Expand Access to Career Training and Certifications
RESTON, VA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- MedCerts, a leader in online healthcare and IT career training and a Stride Inc. portfolio company, today announced a landmark partnership with eHBCU, the nation’s first digital HBCU consortium. This...
IMA Financial Group Expands in Southeast Region with Valent Group Partnership
Denver, Oct. 02, 2025 (GLOBE NEWSWIRE) -- IMA Financial Group, Inc., a North American insurance brokerage specializing in risk management, wholesale brokerage, and wealth management, today announced a strategic partnership with Valent Group, a...
uniQure Announces Pricing of Upsized $300 Million Public Offering
LEXINGTON, Mass. and AMSTERDAM, Sept. 25, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its previously...
ZenaTech Announces Establishment of Its Global Drone as a Service (DaaS) Business Headquarters in Orlando, Leveraging an Industry Growing at Over 36% Annually
VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service...
uniQure Announces $200 Million Proposed Public Offering
LEXINGTON, Mass. and AMSTERDAM, Sept. 24, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced a $200...
PridCor Therapeutics Principal Investigator Dr. David Putrino Participates in National Long COVID Roundtable Convened by Secretary Robert F. Kennedy Jr.
TUSCALOOSA, Ala., Sept. 23, 2025 (GLOBE NEWSWIRE) -- PridCor Therapeutics today announced that Dr. David Putrino, principal investigator of the company’s SHIELD Study, participated in a national roundtable on Long COVID convened by U.S. Health and...
Wells Fargo serves as presenting sponsor for 2025 Thurgood Marshall College Fund Leadership Institute
Washington, D.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Wells Fargo serves as presenting sponsor for 2025 Thurgood Marshall College Fund Leadership Institute Wells Fargo proudly continues its enduring support as presenting sponsor of the Thurgood...
'Let’s Do It!': 101-Year-Old WWII Veteran Soars in Vintage Biplane
Jim Sharp, an Army veteran who fought in the Battle of the Bulge and served as Sergeant Guard at the Nuremberg Trials, was honored with a free Dream Flight. MANHATTAN, KS, UNITED STATES, September 30, 2025 /EINPresswire.com/ -- The World War II...
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients with treatment-resistant depression and demonstrated rapid, clinically meaningful and durable antidepressant effects, which are...
Flowerbulb.eu Releases Guide to Growing Alliums From Spring to Fall
Nurturing Backyard Ecosystems: Succession Planting With Allium Bulbs PHILADELPHIA, PA, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- Alliums are unique-looking plants that are a gardener’s and pollinator’s best friend. Available in a...
Feeding Pets of the Homeless Expands Annual Fill-a-Vehicle Drive to 12 Dealerships in Four States
Event collects pet food during October to support pets of people experiencing homelessness CARSON CITY, NV, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- What started more than a decade ago as a local challenge at Michael Hohl Chevy...
American Oncology Network and Low Country Cancer Care Welcome Dr. Anton Juncaj
Medical oncologist joins Low Country Cancer Care’s physician team SAVANNAH, Ga., Sept. 09, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its...
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share
SAN JUAN CAPISTRANO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical,...
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
NEW YORK and WALTHAM, Mass., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe...
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering
NEW YORK and WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe...
Rapport Announces Pricing of Public Offering of Common Stock
BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision...
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe...